BHARAT PARENTERALS
|
The Current P/E Ratio of BHARAT PARENTERALS is -23.96.
| Share Price | ₹992.3 | Mar 24,2026 |
| Market Cap | ₹684.7 Cr | |
| Earnings-TTM | ₹-28.6 Cr | TTM-Consolidated Results |
| Price/Earnings | -23.96x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of BHARAT PARENTERALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹684.7 Cr] as on Mar 24,2026
(/) Earnings [ ₹-28.6 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -23.96x ]
Thus, for BHARAT PARENTERALS , the investors are currently willing to pay -23.96 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BHARAT PARENTERALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BHARAT PARENTERALS over the last five years.
Historical PE (Price/Earnings) ratio chart of BHARAT PARENTERALS
PE Ratio Performance Analysis for BHARAT PARENTERALS
- BHARAT PARENTERALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 15.12x.
- BHARAT PARENTERALS 's operated at median p/e ratio of 9.42x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BHARAT PARENTERALS 's p/e ratio peaked in Mar2024 at 44.99x.
- BHARAT PARENTERALS 's p/e ratio hit its five-year low in Mar2025 of 0x.
How does BHARAT PARENTERALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| BHARAT PARENTERALS | -28.58 | -23.96 | 684.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 38.23 | 420,555.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 64.50 | 159,889.0 |
| CIPLA LTD | 4,544.70 | 21.67 | 98,492.9 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 63.41 | 144,073.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.08 | 105,133.0 |
| MANKIND PHARMA LTD | 1,796.65 | 45.66 | 82,039.3 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 18.08 | 89,202.6 |
| LUPIN LTD | 4,669.18 | 22.83 | 106,603.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 21.18 | 74,415.2 |
| ABBOTT INDIA LTD | 1,524.13 | 37.40 | 56,998.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BHARAT PARENTERALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -23.96x |
| Max industry PE | 64.50x |
| Median industry PE | 22.83x |
| Average industry PE | 29.83x |
You may also like the below Video Courses